Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, and ...

Mankind Pharma's net profit surged 29% to Rs 659 cr in Q2 FY25, driven by volume recovery and strong EBITDA margins. Revenue ...

Pharmaceutical M&A came back with a bang during October, after a quiet September. Merck & Co (NYSE: MRK) and AbbVie (NYSE: ...

India's Mankind Pharma reported a stronger-than-expected profit for the second quarter of FY24, driven by higher demand for its medications targeting long-term health conditions like diabetes and ...

On the last trading day, JSW Infrastructure opened at ₹310.95 and closed slightly lower at ₹310.25. The stock reached a high ...

On the last trading day for Baazar Style, the stock opened at ₹343.4 and closed at ₹351.75. During the day, it reached a high ...

Mankind Pharma witnessed a 29% surge in consolidated net profit, reaching Rs 658.88 crore in the second quarter, ending ...

Mankind Pharma reported a significant upturn in its Q2 profits, with a 29% increase in net profit to Rs 658.88 crore, fueled by volume recovery and strong performance in the chronic segment. Revenue ...

The company reported a stronger-than-expected profit, driven by high demand for its drugs for chronic conditions such as ...

Mankind Pharma on Tuesday reported a 29 per cent rise in its consolidated net profit to Rs 658.88 crore for the second ...

The Indian government will sell 2.5% stake in Hindustan Zinc Limited through an offer for sale (OFS) at a floor price of Rs ...